Challenges and new horizons in the periodic fever, aphthous stomatitis, pharingitis and adenitis (PFAPA) syndrome.

Research output: Contribution to journalArticle

9 Citations (Scopus)


Introduction: periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome is a multifactorial autoinflammatory disorder representing a true challenge for differential diagnosis of fevers of unknown origin among children. Areas covered: although current diagnostic criteria confine PFAPA syndrome into the pediatric world, recent evidences have suggested the possible onset of this disease during adulthood as well as the possible relapse over time after spontaneous or treatment-induced resolution in childhood. The number of treatment choices currently available is growing significantly. In this regard, inhibition of interleukin (IL)-1 represents an intriguing promise for PFAPA patients who do not respond to standard therapy or for whom corticosteroid administration is unsuitable. Expert commentary: the challenges associated with the discovery of pathogenetic pathways and treatment alternatives in PFAPA syndrome are immense, reflected by the small number of studies currently in progress. As new mechanisms underlying the regulation of innate immunity are discovered and novel therapeutic approaches are adopted, the next decade promises many exciting advances to manage and treat patients with PFAPA syndrome.
Original languageEnglish
Pages (from-to)165-171
Number of pages7
JournalExpert Opinion on Orphan Drugs
Publication statusPublished - 2017


  • PFAPA syndrome


Dive into the research topics of 'Challenges and new horizons in the periodic fever, aphthous stomatitis, pharingitis and adenitis (PFAPA) syndrome.'. Together they form a unique fingerprint.

Cite this